The treatment consists of recombinant human granulocyte-colony-stimulating factor (G-CSF), 5-aminosalicylates (ASA), probiotics, and also high dose of vitamin E. In our group, two GSD Ib siblings developed IBD [21]. The gene discussed is CSF3; the disease is inflammatory bowel disease.